At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BEAT Heartbeam Inc
Market Closed 06-26 16:00:00 EDT
0.6754
+0.0354
+5.53%
盘后0.6600
-0.0154-2.28%
19:47 EDT
High0.6869Low0.6342Vol685.19K
Open0.6495D1 Closing0.6400Amplitude8.23%
Mkt Cap37.49MTradable Cap32.05MTotal Shares55.51M
T/O453.44KT/O Rate1.44%Tradable Shares47.45M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

HeartBeam (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy
TIPRANKS  ·  06-26 02:30
HeartBeam (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy
HeartBeam CEO Robert Eno to Step Down; Founder Branislav Vajdic to Lead Operations
MT Newswires Live  ·  06-25 18:32
HeartBeam CEO Robert Eno to Step Down; Founder Branislav Vajdic to Lead Operations
HeartBeam restructures to license 3D ECG technology
TIPRANKS  ·  06-25 05:48
HeartBeam restructures to license 3D ECG technology
Heartbeam CEO Eno Transitions to Consulting Role as Part of Reorganization
Dow Jones  ·  06-25 05:23
Heartbeam CEO Eno Transitions to Consulting Role as Part of Reorganization
HeartBeam announces strategic shift to ambulatory ECG signal platform
TIPRANKS  ·  06-25
HeartBeam announces strategic shift to ambulatory ECG signal platform
Heartbeam Shifts Strategy to License 3D ECG Platform to Partners to Drive Global Adoption
Reuters  ·  06-25
Heartbeam Shifts Strategy to License 3D ECG Platform to Partners to Drive Global Adoption
Heartbeam - Advancing Toward Heart Attack Detection as Key Platform Expansion
THOMSON REUTERS  ·  06-25
Heartbeam - Advancing Toward Heart Attack Detection as Key Platform Expansion
Heartbeam - to License 3D Ecg Technology to Partners, Moves Beyond Direct Device Sales
THOMSON REUTERS  ·  06-25
Heartbeam - to License 3D Ecg Technology to Partners, Moves Beyond Direct Device Sales
Heartbeam Announces Strategic Shift to Accelerate Global Adoption of Its Ambulatory Ecg Signal Platform and Leadership Transition
THOMSON REUTERS  ·  06-25
Heartbeam Announces Strategic Shift to Accelerate Global Adoption of Its Ambulatory Ecg Signal Platform and Leadership Transition
HeartBeam (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection
TIPRANKS  ·  06-24
HeartBeam (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection
HeartBeam Grants Founder Performance-Based Equity and Bonus Incentives
TIPRANKS  ·  06-23
HeartBeam Grants Founder Performance-Based Equity and Bonus Incentives
HeartBeam grants President Branislav Vajdic 2,800,000 performance-based RSUs
Reuters  ·  06-23
HeartBeam grants President Branislav Vajdic 2,800,000 performance-based RSUs
Press Release: PEET'S COFFEE LAUNCHES NATIONWIDE SEARCH FOR ITS FIRST-EVER "CHIEF PLAYLIST OFFICER" TO BEAT AMERICA'S 3PM SLUMP
Dow Jones  ·  06-03
Press Release: PEET'S COFFEE LAUNCHES NATIONWIDE SEARCH FOR ITS FIRST-EVER "CHIEF PLAYLIST OFFICER" TO BEAT AMERICA'S 3PM SLUMP
HeartBeam (NASDAQ: BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk
TIPRANKS  ·  06-03
HeartBeam (NASDAQ: BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk
HeartBeam study in JACC Advances shows at-home ECG algorithm identifies heart attack risk in chest pain patients
Reuters  ·  06-02
HeartBeam study in JACC Advances shows at-home ECG algorithm identifies heart attack risk in chest pain patients
HeartBeam posts investor deck on at-home, cable-free synthesized 12-lead ECG platform for arrhythmia assessment
Reuters  ·  06-02
HeartBeam posts investor deck on at-home, cable-free synthesized 12-lead ECG platform for arrhythmia assessment
HeartBeam (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
TIPRANKS  ·  05-27
HeartBeam (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
Heartbeam Is Maintained at Buy by HC Wainwright & Co.
Dow Jones  ·  05-22
Heartbeam Is Maintained at Buy by HC Wainwright & Co.
HeartBeam price target lowered to $2.50 from $5.50 at H.C. Wainwright
TIPRANKS  ·  05-22
HeartBeam price target lowered to $2.50 from $5.50 at H.C. Wainwright
Heartbeam, Inc. : H.c. Wainwright Cuts Target Price to $2.5 From $5.5
THOMSON REUTERS  ·  05-22
Heartbeam, Inc. : H.c. Wainwright Cuts Target Price to $2.5 From $5.5

Introduction

Company Name.
Heartbeam Inc
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
Issue price:
--